These genes included CAPZB, DSTN, GYS1, IQGAP1, MYH9, NDUFA11, NDUFS1, OXSM (Figure 4B–D, Table 2), which were then utilized to establish a prognostic model for DLBCL patients. This evidence concerns the gene MYH9 and diffuse large B-cell lymphoma.